Cardinal Health, Inc. (CAH) Stock Analysis

Q: What is the CAH stock price target?

Take-profit $223.44 (+15.8% upside). Prior stop was $181.20.

Q: What are the risks of investing in CAH?

Concentration risk — Supplier: sole supplier; Quality below floor (3.4 < 4.0); Quality below floor (3.4 < 4.0); Momentum score 4.2/10 — below 4.5 minimum.

Q: Is CAH overvalued or undervalued?

Cardinal Health, Inc. trades at a P/E of 29.4 (forward 16.6). TrendMatrix value score: 6.7/10. Overall verdict: Sell.

Q: What do analysts say about CAH?

22 analysts cover CAH with a consensus score of 4.2/5. Average price target: $248.

Q: What does Cardinal Health, Inc. do?

Cardinal Health is a global healthcare services and products company with two segments: Pharmaceutical and Specialty Solutions (drug distribution) and Global Medical Products and Distribution (manufacturing and sourcing of medical devices and surgical supplies).

Oversold Bounce setup

SellModerate ConfidenceUpdated 2026-05-01

Healthcare · Medical Distribution

Sell if holding. Engine safety override at $195.25: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10 and A.R:R 2.6:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality.

Cardinal Health is a global healthcare services and products company with two segments: Pharmaceutical and Specialty Solutions (drug distribution) and Global Medical Products and Distribution (manufacturing and sourcing of medical devices and surgical supplies).

$195.25+15.8% A.UpsideScore 5.2/10#3 of 5 Medical Distribution

Stop $181.20Target $223.44(analyst − 10%)A.R:R 2.6:1

Analyst target$248.27+27.2%15 analysts

$223.44our TP

$195.25price

$248.27mean

$275

Passes 6/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear). Fails on weak momentum. Suitability: moderate.

Thesis

Rewards

No bull case signals

Risks

Concentration risk — Supplier: sole supplier

Quality below floor (3.4 < 4.0)

Key Metrics

P/E (TTM)29.4

P/E (Fwd)16.6

Mkt Cap$45.4B

EV/EBITDA12.5

Profit Mgn0.6%

ROE—

Rev Growth11.0%

Beta0.65

Dividend1.06%

Rating analysts22

Quality Signals

Piotroski F5/9

Options Flow

P/C1.16bearish

IV40%normal

Max Pain$160-18.1% vs spot

Concentration Risks(10-K Item 1A)

HIGHSuppliersole supplier
10-K Item 1A: 'we procure certain components and raw materials from a sole supplier'

Material Events(8-K, last 90d)

2026-03-23Item 5.02LOW
Board Chair Gregory B. Kenny retired effective March 20, 2026; Patricia A. Hemingway Hall appointed Board Chair immediately. No disagreement with Company on any matter cited.
SEC filing →
2026-03-05Item 5.02LOW
Chief Accounting Officer Mary Scherer notified intent to retire in February 2027. Company initiating search for successor; Scherer to continue as CAO through transition.
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value6.715%1.00

Quality3.415%0.51

Growth2.615%0.39

Momentum4.210%0.42

Sentiment7.810%0.78

Insider Activity5.010%0.50

Peer Rank4.610%0.46

Technical Setup7.85%0.39

Risk Profile6.45%0.32

Catalyst8.25%0.41

Overall (Σ contributions)5.18

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth

0.0

Revenue Growth

5.2

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin

0.0

Net Margin

0.3

Operating Margin

0.6

Roa

2.4

Current Ratio

3.6

Moat

5.0

Piotroski F

5.6

Fcf Quality

10.0

Excellent cash conversion: 312% FCF/NINo competitive moat

GatesMomentum 4.2<4.5A.R:R 2.6 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEAROversold BounceSuitability: Moderate

RSI

27 · Oversold

↓ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $185.80Resistance $217.77

Price Targets

$181

$223

A.Upside+14.4%

A.R:R2.6:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Quality below floor (3.4 < 4.0)

! Momentum score 4.2/10 — below 4.5 minimum

Earnings

4/4 beats

Next Earnings2026-04-30 (nulld)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is CAH stock a buy right now?

Sell if holding. Engine safety override at $195.25: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10 and A.R:R 2.6:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality. Chart setup: Oversold RSI 27, near Bollinger lower, volume surge. Prior stop was $181.20. Score 5.2/10, moderate confidence.

What is the CAH stock price target?

Take-profit target: $223.44 (+15.8% upside). Prior stop was $181.20. Stop-loss: $181.20.

What are the risks of investing in CAH?

Concentration risk — Supplier: sole supplier; Quality below floor (3.4 < 4.0).

Is CAH overvalued or undervalued?

Cardinal Health, Inc. trades at a P/E of 29.4 (forward 16.6). TrendMatrix value score: 6.7/10. Verdict: Sell.

What do analysts say about CAH?

22 analysts cover CAH with a consensus score of 4.2/5. Average price target: $248.

What does Cardinal Health, Inc. do?Cardinal Health is a global healthcare services and products company with two segments: Pharmaceutical and Specialty...